Is vaccination a feasible public health strategy against fatal Borna disease virus 1 (BoDV-1) encephalitis? An epidemiological perspective

• Kirsten Pörtner ,

  * E-mail: poertnerk@rki.de

  Affiliation Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany

  https://orcid.org/0000-0001-8191-8056

  ⨯
• Christina Frank,

  Affiliation Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany

  ⨯
• Hendrik Wilking,

  Affiliation Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany

  ⨯
• Klaus Stark,

  Affiliation Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany

  ⨯
• Christiane Herden,

  Affiliation Institute for Veterinary Pathology, Justus Liebig-University Gießen, Gießen, Germany

  ⨯
• Martin Beer,

  Affiliation Institute of Diagnostic Virology, Friedrich Loeffler Institute, Greifswald- Insel Riems, Germany

  ⨯
• Dennis Rubbenstroth,

  Affiliation Institute of Diagnostic Virology, Friedrich Loeffler Institute, Greifswald- Insel Riems, Germany

  ⨯
• Dennis Tappe

  Affiliation Reference Laboratory for Bornaviruses, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany

  ⨯